30.84
전일 마감가:
$31.87
열려 있는:
$31.74
하루 거래량:
218.58K
Relative Volume:
0.60
시가총액:
$1.25B
수익:
$1.46B
순이익/손실:
$92.09M
주가수익비율:
13.67
EPS:
2.2555
순현금흐름:
$47.29M
1주 성능:
-1.09%
1개월 성능:
-10.27%
6개월 성능:
-24.04%
1년 성능:
+26.13%
Phibro Animal Health Corp Stock (PAHC) Company Profile
명칭
Phibro Animal Health Corp
전화
201-329-7300
주소
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corp
|
30.84 | 1.31B | 1.46B | 92.09M | 47.29M | 2.2555 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
8.87 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.56 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
77.26 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
551.47 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Neutral |
| 2025-07-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-06-16 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | 개시 | JP Morgan | Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Underperform |
| 2022-12-21 | 개시 | ROTH Capital | Buy |
| 2022-07-25 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-11-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2021-07-07 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-08-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-01-28 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-09-05 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | 재확인 | BofA/Merrill | Underperform |
| 2019-06-11 | 개시 | Barclays | Underweight |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-05-09 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2017-08-23 | 재개 | BofA/Merrill | Underperform |
| 2017-06-02 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | 개시 | Piper Jaffray | Overweight |
| 2016-11-11 | 다운그레이드 | Macquarie | Neutral → Underperform |
| 2016-11-10 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2016-04-11 | 재확인 | Guggenheim | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2016-01-15 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2015-09-30 | 개시 | Gabelli & Co | Buy |
| 2015-04-24 | 재확인 | Barclays | Overweight |
| 2015-04-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | 개시 | Barclays | Overweight |
모두보기
Phibro Animal Health Corp 주식(PAHC)의 최신 뉴스
Should You Continue to Hold PAHC Stock in Your Portfolio? - Yahoo Finance
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares? - Yahoo Finance
PAHC News | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
PAHC - Finviz
PAHC Stock: What's Driving Phibro's Animal Health Growth - Yahoo Finance
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Phibro Animal Health Corp (PAHC) Stock Price Today & Analysis - Gotrade
Phibro Animal Health (PAHC) Q3 2026 Earnings Call Transcript - MLQ.ai
How The Story Is Shifting For Phibro Animal Health (PAHC) As Analysts Reset Fair Value - Yahoo Finance
Why Phibro Animal Health (PAHC) Stock Is Trading Up Today - Yahoo Finance
Phibro Animal Health Up 10% After Insider Move - Bez Kabli
Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock By Investing.com - Investing.com South Africa
Phibro Animal Health director E. Thomas Corcoran buys $317,700 in stock - Investing.com UK
Phibro Animal Health (PAHC) director buys 10,000 shares in market - Stock Titan
Phibro Animal Health Lifts Outlook Amid Strong Q3 - TipRanks
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Implied Volatility Surging for Phibro Stock Options - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Fall 3.1% -- GF Value Sa - GuruFocus
After Plunging 38.0% in 4 Weeks, Here's Why the Trend Might Reverse for Phibro (PAHC) - Yahoo Finance
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Phibro's CEO transition puts this insider sale in context - AOL.com
Phibro's CEO transition puts this insider sale in context - The Motley Fool
Phibro Animal Health (PAHC) major holder adopts 10b5-1 sale plan - Stock Titan
Phibro leaders to address investors at Stifel 'Jaws & Paws' in New York - Stock Titan
Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference - Yahoo Finance
PAHC Technical Analysis & Stock Price Forecast - Intellectia AI
Phibro Animal Health Corporation (PAHC) Price Target Cut to $44 by Citi Amid Sector Pressure - Insider Monkey
Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Phibro (PAHC) Q1 2026 Earnings: EPS $0.76 Beats EstimatesSocial Buy Zones - Newser
PAHC Stock Price, Quote & Chart | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
Barclays PLC holds 263,695 shares in Phibro (NASDAQ: PAHC) - Stock Titan
PAHC Maintained by Citigroup -- Price Target Lowered to $44 - GuruFocus
Phibro Animal Health Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Phibro Animal Health Sales Grow 10 Percent to 383 Million Dollars - HarianBasis.co
Earnings call transcript: Phibro Animal Health Q3 2026 sees earnings beat, stock tumbles - Investing.com
Phibro Animal Health Corporation (PAHC) Announces Financial Results for Q3 - Insider Monkey
Phibro Animal Health Corp (FRA:PB8) Stock Price & 30 Year Financial Data - GuruFocus
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Q2 2026 Phibro Animal Health Corp Earnings Call Transcript - GuruFocus
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Down 30.9% in 4 Weeks, Here's Why Phibro (PAHC) Looks Ripe for a Turnaround - Yahoo Finance
Phibro Animal Health Corp (PAHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Phibro Animal Health Corp 주식 (PAHC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| CORCORAN E THOMAS | Director |
May 29 '26 |
Buy |
31.77 |
10,000 |
317,700 |
41,459 |
| BENDHEIM JACK | President and CEO |
May 06 '26 |
Sale |
57.37 |
7,040 |
403,850 |
60,680 |
| BENDHEIM JACK | President and CEO |
May 05 '26 |
Sale |
55.80 |
7,040 |
392,810 |
67,720 |
| BENDHEIM JACK | President and CEO |
May 07 '26 |
Sale |
48.49 |
4,528 |
219,568 |
56,152 |
| BENDHEIM JACK | President and CEO |
Apr 28 '26 |
Sale |
55.91 |
7,040 |
393,575 |
88,840 |
| BENDHEIM JACK | President and CEO |
Apr 29 '26 |
Sale |
52.92 |
7,040 |
372,553 |
81,800 |
| BENDHEIM JACK | President and CEO |
Apr 30 '26 |
Sale |
52.76 |
7,040 |
371,465 |
74,760 |
| BENDHEIM JACK | President and CEO |
Apr 21 '26 |
Sale |
55.98 |
7,040 |
394,081 |
109,960 |
| BENDHEIM JACK | President and CEO |
Apr 22 '26 |
Sale |
54.29 |
7,040 |
382,185 |
102,920 |
| BENDHEIM JACK | President and CEO |
Apr 23 '26 |
Sale |
54.09 |
7,040 |
380,826 |
95,880 |
자본화:
|
볼륨(24시간):